USFDA18 Dec 2024, 08:56 pm
FDC LTD. Receives US FDA Approval for Cefixime 400 mg Tablets
AI Summary
FDC LTD. has announced that it has received final approval from the US Food and Drug Administration (US FDA) for the company's Abbreviated New Drug Application (ANDA) for Cefixime 400 mg Tablets. This announcement comes after the US FDA inspection at the company's manufacturing facility located at Baddi, Himachal Pradesh. The approval is a significant milestone for the company, and it is hoped that it will strengthen the company's position in the pharmaceutical industry.
Key Highlights
- FDC LTD. has received final approval from US FDA for ANDA - Cefixime 400 mg tablets
- The approval follows a US FDA inspection at the company's manufacturing facility in Baddi, Himachal Pradesh
- The company's ANDA for Cefixime 400 mg tablets has been approved by the US FDA
- This approval is a significant milestone for FDC LTD.
- The approval is expected to strengthen FDC LTD.'s position in the pharmaceutical industry